Fig. 3From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseHypothetical model for biomarker dynamics in the progression of Alzheimer’s disease [4]Back to article page